Expenditure

Improving access to medicines

A new WHO report provides insight into how countries in the WHO European Region can improve access and reduce medicine prices through strategic and well-planned procurement processes. It also addresses collaboration within and across countries to improve availability of affordable medicines for patients in the Region. Countries in the Region have varying capacity and negotiating

Improving access to medicines Read More »

Health at a Glance

There are two new reports from the OECD in the ‘Health at a Glance’ series: Health at a Glance: Europe 2016 which is the fourth edition looking at health in the EU and presents key indicators of health and health systems in the 28 EU countries, 5 candidate countries to the EU and 3 EFTA

Health at a Glance Read More »

Pharmaceutical Expenditure And Policies

Across OECD countries, pharmaceutical spending was around US$800 billion in 2013, accounting for about 20{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96} of total health spending on average (hospital consumption and retail). This paper ‘Pharmaceutical expenditure and policies: past trends and future challenges‘ examines the drivers of recent spending trends, highlighting differences across therapeutic classes. While the consumption of medicines continues to

Pharmaceutical Expenditure And Policies Read More »

OECD Health Statistics 2016

The online database ‘OECD health statistics 2016‘ has been released and offers the most comprehensive source of comparable statistics on health and health systems across OECD countries. It is an essential tool to carry out comparative analyses and draw lessons from international comparisons of diverse health systems. It includes data on biotechnology, cancer, health care,

OECD Health Statistics 2016 Read More »

Scroll to Top